Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,984 | 92 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $634.75 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $412.23 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $363.25 | 7 | $0 (2024) |
| Amgen Inc. | $198.51 | 9 | $0 (2024) |
| Philips North America LLC | $175.21 | 8 | $0 (2024) |
| Mylan Specialty L.P. | $157.78 | 7 | $0 (2024) |
| Lilly USA, LLC | $124.99 | 1 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $124.56 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $109.24 | 1 | $0 (2024) |
| Baxter Healthcare | $104.15 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,443 | 78 | Boehringer Ingelheim Pharmaceuticals, Inc. ($412.23) |
| 2023 | $541.07 | 14 | GlaxoSmithKline, LLC. ($435.27) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 2 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/18/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $2.92 | General |
| Category: Inflammation | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.84 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Cardiology | ||||||
| 08/22/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $27.36 | General |
| Category: HFCWO | ||||||
| 08/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/21/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Inflammation | ||||||
| 08/19/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $26.67 | General |
| Category: Medical Device | ||||||
| 08/15/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Pulmonology | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $102.64 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Respiratory | ||||||
| 08/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: Inflammation | ||||||
| 07/17/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Inflammation | ||||||
| 07/10/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $81.32 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/09/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $25.43 | General |
| Category: Medical Device | ||||||
| 07/09/2024 | Baxter Healthcare | Hillrom - Monarch Airway Clearance System (Device) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Airway Clearance Device | ||||||
| 07/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/01/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 580 | 645 | $150,067 | $44,951 |
| 2022 | 7 | 808 | 976 | $222,300 | $84,671 |
| 2021 | 8 | 738 | 915 | $234,413 | $87,694 |
| 2020 | 5 | 172 | 177 | $38,161 | $12,549 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 268 | 304 | $58,623 | $17,227 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 196 | 215 | $58,963 | $17,208 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 82 | 92 | $28,355 | $9,246 | 32.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 34 | 34 | $4,126 | $1,269 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 266 | 343 | $79,507 | $30,125 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 194 | 232 | $71,772 | $27,472 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 220 | 273 | $43,287 | $17,049 | 39.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 40 | 40 | $17,436 | $5,933 | 34.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 35 | 35 | $7,084 | $2,440 | 34.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 37 | 37 | $1,661 | $1,004 | 60.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 16 | $1,553 | $647.84 | 41.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 291 | 390 | $120,689 | $46,310 | 38.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 223 | 283 | $65,599 | $24,524 | 37.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 113 | $17,917 | $7,114 | 39.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 44 | 44 | $19,180 | $6,183 | 32.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $4,170 | $1,293 | 31.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 18 | 18 | $3,643 | $1,185 | 32.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 34 | 35 | $2,318 | $768.90 | 33.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 20 | 20 | $898.00 | $316.40 | 35.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 104 | 107 | $24,953 | $8,254 | 33.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 20 | 20 | $6,187 | $2,024 | 32.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 24 | $3,805 | $1,247 | 32.8% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 13 | 13 | $2,631 | $793.00 | 30.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 13 | 13 | $583.70 | $231.14 | 39.6% |
About David Anderson, PA-C
David Anderson, PA-C is a Physician Assistant healthcare provider based in Atascadero, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1649303165.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Anderson, PA-C has received a total of $2,984 in payments from pharmaceutical and medical device companies, with $2,443 received in 2024. These payments were reported across 92 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,984).
As a Medicare-enrolled provider, Anderson has provided services to 2,298 Medicare beneficiaries, totaling 2,713 services with total Medicare billing of $229,866. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Atascadero, CA
- Active Since 03/13/2007
- Last Updated 12/19/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1649303165
Products in Payments
- JARDIANCE (Drug) $452.66
- TEZSPIRE (Biological) $396.63
- AREXVY (Drug) $341.08
- (8874) inCourage (Device) $215.31
- YUPELRI (Drug) $157.78
- AIRSUPRA (Drug) $145.28
- VOQUEZNA (Drug) $124.56
- TRELEGY ELLIPTA (Drug) $123.49
- ELIQUIS (Drug) $109.24
- VRAYLAR (Drug) $102.64
- OFEV (Drug) $84.56
- DUPIXENT (Biological) $81.45
- ZENPEP (Drug) $81.32
- Prolastin-C Liquid (Biological) $71.52
- Hillrom - Monarch Airway Clearance System (Device) $70.13
- Arikayce (Drug) $56.89
- SMARTVEST (Device) $55.77
- NUCALA (Biological) $45.18
- FISHER & PAYKEL HEALTHCARE (Device) $24.65
- Flexitouch Plus (Device) $23.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Atascadero
Mrs. Naomi Waak, Pa, PA
Physician Assistant — Payments: $3,804
Hilary Anderson, Pa-C, PA-C
Physician Assistant — Payments: $2,914
Natalie Laskowicz
Physician Assistant — Payments: $992.51
Kristen Schalck, Pa, PA
Physician Assistant — Payments: $279.02
Christopher Tucker, Pa, PA
Physician Assistant — Payments: $59.22
Mr. Michael Blackwell, Pa-C, PA-C
Physician Assistant